Yongkun Sun

8PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 09, 2026
Irinotecan with trifluridine/tipiracil and bevacizumab for second-line metastatic colorectal cancer: a phase II multicenter study.

Wenwei Yang, Jing Zhang, Ping Liang

|Oct 25, 2024
Phase II Study of Irinotecan, Trifluridine/tipiracil (TAS-102) plus Bevacizumab as a Later-line Therapy for Patients with Metastatic Colorectal Cancer (mCRC): a prospective single-center explorative study.

Baoqi Li, Wenwei Yang, Na Liu

|Jul 27, 2023
Current neoadjuvant therapy for operable locally advanced esophageal cancer.

Wenwei Yang, Yaru Niu, Yongkun Sun

|May 28, 2022
The Deubiquitinase USP39 Promotes Esophageal Squamous Cell Carcinoma Malignancy as a Splicing Factor.

Xiaolin Zhu, Jianlin Ma, Minyi Lu

|Mar 11, 2022
Serum Concentration of CD137 and Tumor Infiltration by M1 Macrophages Predict the Response to Sintilimab plus Bevacizumab Biosimilar in Advanced Hepatocellular Carcinoma Patients.

Wen Zhang, Caifeng Gong, Xuenan Peng

|Aug 16, 2021
The Real-World Practice of Fruquintinib for Chinese Patients with Metastatic Colorectal Cancer.

Yan Song, Tao Qu, Honggang Zhang

Pageof 2

Frequent Collaborators

2 joint publications

Wenwei Yang

1 joint publications

Ju-Fang Shi

1 joint publications

Hong-Da Chen

1 joint publications

Wan-Qing Chen